Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance

By Nawrocka Jolanta   Starczewski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment

By Jakubowska Joanna   Bohdanowicz-Pawlak Anna   Milewicz Andrzej   Szymczak Jadwiga   Bednarek-Tupikowska Grazyna   Demissie Marek  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 378-384

Informa Healthcare

Access to resources Recommend Favorite

Sequential treatment of metformin and clomiphene citrate in clomiphene‐resistant women with polycystic ovary syndrome: a randomized, controlled trial

By George Susan Shanti  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 299-304

Oxford University Press

Access to resources Recommend Favorite